Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-VALSARTAN/HCTZ 12.5MG 320MG TABLET Actual shortage 2018-10-23 2019-07-15 65369
TEVA-VALSARTAN/HCTZ 25MG 160MG TABLET Actual shortage 2018-10-23 2019-07-15 65372
TEVA-VALSARTAN/HCTZ 25MG 160MG TABLET Actual shortage 2018-10-23 2019-07-15 65375
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Actual shortage 2018-10-23 2020-02-13 65490
TEVA-PRAZOSIN 5MG TABLET Resolved 2018-10-23 2019-04-27 65494
ACT FAMCICLOVIR 125MG TABLET Actual shortage 2018-10-23 2018-10-23 65497
ACT FAMCICLOVIR 500MG TABLET Actual shortage 2018-10-23 2018-10-23 65500
ACT FAMCICLOVIR 250MG TABLET Actual shortage 2018-10-23 2018-10-23 65502
ACT FAMCICLOVIR 500MG TABLET Actual shortage 2018-10-23 2018-10-23 65507
ACT LOVASTATIN 20MG TABLET Actual shortage 2018-10-23 2019-03-14 65510
ACT LOVASTATIN 40MG TABLET Actual shortage 2018-10-23 2019-03-14 65513
ACT OLOPATADINE 0.2% 0.2% SOLUTION Actual shortage 2018-10-23 2018-10-23 65516
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519
MITOMYCIN FOR INJECTION 20MG POWDER FOR SOLUTION Actual shortage 2018-11-01 2021-10-14 65987
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999

Showing 341 to 360 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114

Showing 161 to 180 of 250